Ligand profile
ZINC15637018
Virtual-screening candidate from ZINC.
Bound to: KP13_02423 — tRNA (guanine-N(1)-)-methyltransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC15637018- UniProt (similar protein)
B1MDI3- Tanimoto
- 0.724
- Target protein
- KP13_02423
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 66.6
- −1 ≤ LogP ≤ 5 3.23
- MW ≤ 500 Da 250.3
- LogP ≤ 5 3.23
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 66.6
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1nc2ccc(Oc3ccc4nc[nH]c4c3)cc2[nH]1c1nc2ccc(Oc3ccc4nc[nH]c4c3)cc2[nH]1
InChI=1S/C14H10N4O/c1-3-11-13(17-7-15-11)5-9(1)19-10-2-4-12-14(6-10)18-8-16-12/h1-8H,(H,15,17)(H,16,18)InChI=1S/C14H10N4O/c1-3-11-13(17-7-15-11)5-9(1)19-10-2-4-12-14(6-10)18-8-16-12/h1-8H,(H,15,17)(H,16,18)
BDZBAWNOKFDVRQ-UHFFFAOYSA-NBDZBAWNOKFDVRQ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 5OB
- Homolog
- B1MDI3
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC15637018 →
- ZINC ZINC20 ZINC15637018 →
- UniProt UniProt B1MDI3 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC15637018”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02423.
PDB 89
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 38
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).